Total Payments
$1,034
2024 Payments
$210.91
Companies
14
Transactions
54
Medicare Patients
10,532
Medicare Billing
$13.1M
Payment Breakdown by Category
Food & Beverage$1,034 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,034 | 54 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $343.21 | 24 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $140.07 | 6 | $0 (2024) |
| Ocular Therapeutix, Inc. | $96.66 | 1 | $0 (2024) |
| Biogen, Inc. | $79.79 | 4 | $0 (2022) |
| ABBVIE INC. | $70.53 | 3 | $0 (2024) |
| Alimera Sciences, Inc. | $56.68 | 4 | $0 (2024) |
| Mallinckrodt LLC | $46.92 | 3 | $0 (2018) |
| BOSTON SCIENTIFIC CORPORATION | $45.43 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $44.80 | 3 | $0 (2021) |
| Johnson & Johnson Surgical Vision, Inc. | $38.96 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $210.91 | 6 | Ocular Therapeutix, Inc. ($96.66) |
| 2023 | $89.13 | 4 | Regeneron Healthcare Solutions, Inc. ($28.17) |
| 2022 | $236.12 | 12 | Biogen, Inc. ($79.79) |
| 2021 | $32.81 | 2 | Novartis Pharmaceuticals Corporation ($17.00) |
| 2020 | $54.88 | 3 | Genentech USA, Inc. ($24.18) |
| 2019 | $70.29 | 3 | Johnson & Johnson Surgical Vision, Inc. ($38.96) |
| 2018 | $60.96 | 4 | Genentech USA, Inc. ($44.31) |
| 2017 | $279.00 | 20 | Genentech USA, Inc. ($128.09) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/06/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/18/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $96.66 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 05/28/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: EYE CARE | ||||||
| 04/30/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 12/20/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/29/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $21.01 | General |
| 11/27/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/31/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: EYE CARE | ||||||
| 11/30/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/07/2022 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $22.04 | General |
| 11/01/2022 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Ophthalmology | ||||||
| 10/26/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/13/2022 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $19.84 | General |
| 09/27/2022 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $16.43 | General |
| 09/08/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: RETINA | ||||||
| 07/05/2022 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $21.48 | General |
| 06/08/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/16/2022 | Genentech USA, Inc. | SUSVIMO (Drug), VABYSMO | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/02/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/19/2022 | Genentech USA, Inc. | Lucentis (Biological), SUSVIMO | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Ophthalmology | ||||||
| 05/18/2021 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/09/2021 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Ophthalmology | ||||||
| 09/22/2020 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: RETINA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 2,518 | 10,507 | $8.9M | $3.0M |
| 2022 | 10 | 2,747 | 11,658 | $7.8M | $2.9M |
| 2021 | 11 | 2,664 | 14,574 | $8.5M | $3.4M |
| 2020 | 9 | 2,603 | 18,068 | $9.2M | $3.7M |
Total Patients
10,532
Total Services
54,807
Medicare Billing
$13.1M
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 259 | 3,200 | $4.8M | $2.2M | 46.0% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 40 | 944 | $1.2M | $205,399 | 16.8% |
| 67028 | Injection of drug into eye | Office | 2023 | 323 | 1,614 | $1.6M | $147,274 | 9.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 45 | 600 | $308,000 | $109,913 | 35.7% |
| J3490 | Unclassified drugs | Office | 2023 | 24 | 46 | $311,370 | $82,934 | 26.6% |
| 92134 | Imaging of retina | Office | 2023 | 778 | 2,440 | $182,856 | $67,778 | 37.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 394 | 867 | $147,390 | $54,065 | 36.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 411 | 548 | $131,520 | $43,103 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 196 | 196 | $62,080 | $21,671 | 34.9% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 13 | 14 | $75,082 | $11,363 | 15.1% |
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 12 | 13 | $22,074 | $5,007 | 22.7% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 23 | 25 | $10,200 | $878.64 | 8.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 237 | 2,562 | $3.8M | $1.8M | 47.6% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 145 | 3,357 | $1.7M | $758,180 | 44.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 348 | 1,579 | $1.6M | $143,132 | 9.0% |
| 92134 | Imaging of retina | Office | 2022 | 854 | 2,503 | $187,545 | $70,567 | 37.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 433 | 801 | $130,780 | $50,094 | 38.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 413 | 519 | $116,570 | $43,361 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 247 | 247 | $74,856 | $28,438 | 38.0% |
| 67210 | Destruction of growth of retina using a laser | Office | 2022 | 38 | 51 | $86,598 | $18,546 | 21.4% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2022 | 15 | 20 | $40,000 | $4,892 | 12.2% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 17 | 19 | $7,394 | $658.35 | 8.9% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2021 | 226 | 7,080 | $3.6M | $1.8M | 49.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 149 | 1,718 | $2.6M | $1.3M | 49.4% |
| 67028 | Injection of drug into eye | Office | 2021 | 354 | 1,831 | $1.9M | $171,456 | 9.1% |
About Dr. David Johnson, MD
Dr. David Johnson, MD is a Ophthalmology healthcare provider based in West Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811942527.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Johnson, MD has received a total of $1,034 in payments from pharmaceutical and medical device companies, with $210.91 received in 2024. These payments were reported across 54 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,034).
As a Medicare-enrolled provider, Johnson has provided services to 10,532 Medicare beneficiaries, totaling 54,807 services with total Medicare billing of $13.1M. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location West Columbia, SC
- Active Since 05/23/2006
- Last Updated 03/30/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1811942527
Products in Payments
- Lucentis (Biological) $254.29
- DEXTENZA (Drug) $96.66
- EYLEA HD (Biological) $90.15
- OZURDEX (Drug) $84.62
- ACTHAR (Biological) $46.92
- GENERAL - VASCULAR INTERVENTION (Device) $45.43
- BEOVU (Drug) $44.80
- VABYSMO (Drug) $39.74
- Tecnis 1-piece IOL (Device) $38.96
- Vabysmo (Drug) $31.68
- EYLEA (Biological) $30.48
- Iluvien (Biological) $28.18
- Cimerli (Biological) $22.59
- EYLEA AFLIBERCEPT INJECTION (Biological) $19.44
- SUSVIMO (Drug) $17.50
- YUTIQ (Drug) $14.27
- Iluvien (Drug) $14.23
- JARDIANCE (Drug) $13.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in West Columbia
William Clark, Md, MD
Ophthalmology — Payments: $1.0M
Ophthalmology $1.0M
John Wells, Md, MD
Ophthalmology — Payments: $38,502
Ophthalmology $38,502
Bethany Bray, M.d, M.D
Ophthalmology — Payments: $11,414
Ophthalmology $11,414
Teresa Fowler, Md, MD
Ophthalmology — Payments: $4,971
Ophthalmology $4,971
Dr. John Payne, Md, MD
Ophthalmology — Payments: $1,527
Ophthalmology $1,527
Nitin Nigam, Md, MD
Ophthalmology — Payments: $1,378
Ophthalmology $1,378